Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure
Clinical trial NCT03387215 · COMPLETED
Trial details
- NCT number
- NCT03387215
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2020-03-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.